The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells

Elena Pedraz‐Cuesta(University of Copenhagen), Stine F. Pedersen(University of Copenhagen)
BMC Cancer
May 15, 2015
Cited by 21


Related Papers